Nicholas G Mowbray1, David Griffith2, Mohammed Hammoda3, Guy Shingler3, Amir Kambal3, Bilal Al-Sarireh3. 1. Swansea University, Singleton Park, Swansea SA2 8PP, UK. Electronic address: ngmowbray@doctors.org.uk. 2. Royal Devon & Exeter Hospital, Barrack Road, Exeter EX2 5DW, UK. 3. Morriston Hospital, Heol Maes Eglwys, Morriston, Swansea SA6 6NL, UK.
Abstract
BACKGROUND: The neutrophil-to-lymphocyte ratio (NLR) is thought to reflect cancer disease burden. To assess the prognostic ability of the NLR on overall survival in patients with resectable, pancreatic cancer a meta-analysis of published literature was undertaken. METHOD: A systematic review was performed independently by two authors using PubMed, Ovid MEDLINE and Embase databases. Included studies detailed the pre-operative NLR and overall survival of pancreatic cancer patients. RESULTS: Of the 214 studies retrieved using the search strategy, 8 studies involving 1519 patients were included in the meta-analysis. Only one study did not find a statistically significant association between a high NLR and OS. The pooled Hazard Ratio was 1.77 (95% CI [1.45-2.15]; p < 0.01). The NLR cut-off values ranged from 2 to 5. There was low to moderate inter-study heterogeneity (I2 = 31%; p = 0.17), a low risk of intra-study bias, and potentially 3 unpublished (negative) studies. CONCLUSIONS: A high pre-operative NLR indicates a worse prognosis than in patients with a low NLR. There is potential to use the NLR to direct therapies. A specific cut-off value has not been established from this study and so further research is required.
BACKGROUND: The neutrophil-to-lymphocyte ratio (NLR) is thought to reflect cancer disease burden. To assess the prognostic ability of the NLR on overall survival in patients with resectable, pancreatic cancer a meta-analysis of published literature was undertaken. METHOD: A systematic review was performed independently by two authors using PubMed, Ovid MEDLINE and Embase databases. Included studies detailed the pre-operative NLR and overall survival of pancreatic cancerpatients. RESULTS: Of the 214 studies retrieved using the search strategy, 8 studies involving 1519 patients were included in the meta-analysis. Only one study did not find a statistically significant association between a high NLR and OS. The pooled Hazard Ratio was 1.77 (95% CI [1.45-2.15]; p < 0.01). The NLR cut-off values ranged from 2 to 5. There was low to moderate inter-study heterogeneity (I2 = 31%; p = 0.17), a low risk of intra-study bias, and potentially 3 unpublished (negative) studies. CONCLUSIONS: A high pre-operative NLR indicates a worse prognosis than in patients with a low NLR. There is potential to use the NLR to direct therapies. A specific cut-off value has not been established from this study and so further research is required.
Authors: Junya Toyoda; Kota Sahara; Shishir K Maithel; Daniel E Abbott; George A Poultsides; Christopher Wolfgang; Ryan C Fields; Jin He; Charles Scoggins; Kamran Idrees; Perry Shen; Itaru Endo; Timothy M Pawlik Journal: Ann Surg Oncol Date: 2022-06-29 Impact factor: 4.339
Authors: Gerd Jomrich; Elisabeth S Gruber; Daniel Winkler; Marlene Hollenstein; Michael Gnant; Klaus Sahora; Martin Schindl Journal: J Gastrointest Surg Date: 2019-03-28 Impact factor: 3.452
Authors: David T Pointer; David Roife; Benjamin D Powers; Gilbert Murimwa; Sameh Elessawy; Zachary J Thompson; Michael J Schell; Pamela J Hodul; Jose M Pimiento; Jason B Fleming; Mokenge P Malafa Journal: BMC Cancer Date: 2020-08-11 Impact factor: 4.430